Investigation of the Effect of Rifampicin Resistance and Risk Factors on Recovery Rates After DAIR Procedure in Patients with Prosthetic Joint Infection

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2023 Aug 22

PMID 37605214

Authors

Gergely Krizsan

Imre Sallai

Daniel Sandor Veres

Gyula Prinz

Mate Kovacs

Gabor Skaliczki

Affiliations

Soon will be listed here.

Abstract

Background: Rifampicin plays a key role in the management of prosthetic joint infections (PJIs), however, the emergence of rifampicin resistance is associated with less favourable clinical outcomes. The purpose of this study was to investigate the impact of rifampicin resistance and other patient-related factors on recovery rates among patients with PJI undergoing debridement, antibiotics and implant retention (DAIR).

Methods: We reviewed medical records and microbiology reports of 67 patients (37 males and 30 females) undergoing DAIR due to PJI between 2014 and 2021. Patient-related factors, co-morbidities and microbiological reports were collected and reviewed. Forty-four patients had hip, 21 had knee, 1 had shoulder and 1 had elbow joint infection. Obtained data were statistically analysed with a logistic regression model.

Results: Rifampicin-sensitive organism was isolated in 47 cases. Recovery rate was 72.3% in the sensitive and 76.9% in the resistant group. We found no significant effect of rifampicin resistance on the probability of recovery. Age and diabetes mellitus showed negative clinical impact on recovery. Staphylococcus aureus and coagulase-negative Staphylococci were predominant in the rifampicin-sensitive (66.6% of the isolates) and Gram-negative rods in the resistant group (65.2%).

Conclusions: Based on our results, higher age and diabetes mellitus may have a clinically relevant negative impact on clinical outcome, however, this effect was not statistically significant. This may be due to the limited number of patients included in this study. We observed no clinically relevant effect of rifampicin-resistance, sex and body mass index (BMI) on recovery rates among patients undergoing DAIR due to PJI.

References

Berbari E, Hanssen A, Duffy M, Steckelberg J, Ilstrup D, Harmsen W . Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998; 27(5):1247-54. DOI: 10.1086/514991. View

Nikolaus O, McLendon P, Hanssen A, Mabry T, Berbari E, Sierra R . Factors Associated With 20-Year Cumulative Risk of Infection After Aseptic Index Revision Total Knee Arthroplasty. J Arthroplasty. 2015; 31(4):872-7. DOI: 10.1016/j.arth.2015.10.025. View

Samuel J, Gould F . Prosthetic joint infections: single versus combination therapy. J Antimicrob Chemother. 2009; 65(1):18-23. DOI: 10.1093/jac/dkp398. View

Lowik C, Wagenaar F, van der Weegen W, Poolman R, Nelissen R, Bulstra S . LEAK study: design of a nationwide randomised controlled trial to find the best way to treat wound leakage after primary hip and knee arthroplasty. BMJ Open. 2017; 7(12):e018673. PMC: 5770823. DOI: 10.1136/bmjopen-2017-018673. View

Costerton J, Montanaro L, Arciola C . Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005; 28(11):1062-8. DOI: 10.1177/039139880502801103. View

Sendi P, Lotscher P, Kessler B, Graber P, Zimmerli W, Clauss M . Debridement and implant retention in the management of hip periprosthetic joint infection: outcomes following guided and rapid treatment at a single centre. Bone Joint J. 2017; 99-B(3):330-336. DOI: 10.1302/0301-620X.99B3.BJJ-2016-0609.R1. View

Berbari E, Osmon D, Lahr B, Eckel-Passow J, Tsaras G, Hanssen A . The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol. 2012; 33(8):774-81. DOI: 10.1086/666641. View

Byren I, Bejon P, Atkins B, Angus B, Masters S, McLardy-Smith P . One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009; 63(6):1264-71. PMC: 2680346. DOI: 10.1093/jac/dkp107. View

Costerton J . Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005; (437):7-11. DOI: 10.1097/00003086-200508000-00003. View

10.

Namba R, Inacio M, Paxton E . Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am. 2013; 95(9):775-82. DOI: 10.2106/JBJS.L.00211. View

11.

El Helou O, Berbari E, Marculescu C, El Atrouni W, Razonable R, Steckelberg J . Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy?. Clin Infect Dis. 2008; 47(7):903-9. DOI: 10.1086/591536. View

12.

Kerkhoffs G, Servien E, Dunn W, Dahm D, Bramer J, Haverkamp D . The influence of obesity on the complication rate and outcome of total knee arthroplasty: a meta-analysis and systematic literature review. J Bone Joint Surg Am. 2012; 94(20):1839-44. PMC: 3489068. DOI: 10.2106/JBJS.K.00820. View

13.

Wimmer M, Hischebeth G, Randau T, Gathen M, Schildberg F, Froschen F . Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections. Diagn Microbiol Infect Dis. 2020; 98(2):115114. DOI: 10.1016/j.diagmicrobio.2020.115114. View

14.

Chen J, Cui Y, Li X, Miao X, Wen Z, Xue Y . Risk factors for deep infection after total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg. 2013; 133(5):675-87. DOI: 10.1007/s00402-013-1723-8. View

15.

Tsang S, Gaston P . Adverse peri-operative outcomes following elective total hip replacement in diabetes mellitus: a systematic review and meta-analysis of cohort studies. Bone Joint J. 2013; 95-B(11):1474-9. DOI: 10.1302/0301-620X.95B11.31716. View

16.

Wouthuyzen-Bakker M, Shohat N, Parvizi J, Soriano A . Risk Scores and Machine Learning to Identify Patients With Acute Periprosthetic Joints Infections That Will Likely Fail Classical Irrigation and Debridement. Front Med (Lausanne). 2021; 8:550095. PMC: 8126631. DOI: 10.3389/fmed.2021.550095. View

17.

Aggarwal V, Tischler E, Lautenbach C, Williams Jr G, Abboud J, Altena M . Mitigation and education. J Arthroplasty. 2013; 29(2 Suppl):19-25. DOI: 10.1016/j.arth.2013.09.028. View

18.

Parvizi J, Tan T, Goswami K, Higuera C, Della Valle C, Chen A . The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018; 33(5):1309-1314.e2. DOI: 10.1016/j.arth.2018.02.078. View

19.

Parvizi J, Heller S, Berend K, Della Valle C, Springer B . Periprosthetic joint infection: the algorithmic approach and emerging evidence. Instr Course Lect. 2015; 64:51-60. View

20.

Tsukayama D, Estrada R, Gustilo R . Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996; 78(4):512-23. DOI: 10.2106/00004623-199604000-00005. View